, Abstract-Background: Emergency physicians regularly encounter agitated patients. In extremely agitated and violent patients, the onset of many traditional medications is relatively slow and often requires additional medication. Ketamine is frequently used in emergency departments (EDs) for procedural sedation and intubation, but has recently been suggested as a treatment for acute agitation. Objectives: We sought to examine the use of ketamine in the treatment of acute agitation in an ED setting, including vital sign changes as a result of this medication. Methods: This is a structured review of an historical cohort of patients over 7 years at two university EDs. Patients were included if they received ketamine as treatment for acute agitation. Abstracted data included age, vital signs including hypoxia, any additional medications for agitation, and alcohol/drug intoxication. Results: Ketamine was administered for agitation on 32 visits involving 27 patients. Preadministration systolic blood pressure was 131 ± 20 mm Hg, with an average postadministration increase of 17 ± 25 mm Hg. The average baseline heart rate was 98 ± 23 beats/min, with an average increase of 8 ± 17 beats/min. No patients became hypoxic; 62.5% of patients required additional calming medication. Alcohol or drug intoxication was present in 40.6% of patients. Conclusions: We found ketamine was used rarely, but had few major adverse effects on vital signs even in a population with 21.9% alcohol intoxication. However, a high proportion (62.5%) of patients required additional pharmacologic treatment for agitation, implying that administering ketamine is useful only for initial control of severe agitation. Ó 2015 Elsevier Inc.
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INTRODUCTION
Emergency physicians regularly encounter agitated patients in the emergency department (ED) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Causes of ED-based agitation are numerous, ranging from psychosis to intoxication (2) (3) (4) (5) 8) . Although verbal de-escalation is recommended as first-line treatment, in some cases this can be ineffective and medication administration may be required to prevent these patients from harming themselves or others (10, 12) . However, many of these medications have a relatively slow onset, require empiric dosing, and often require additional medication for calming (10, 13) .
Ketamine is a dissociative agent acting through antagonism of glutamate N-methyl-D-aspartate receptors, which causes a trance-like state resulting in analgesia and amnesia (14) . It is frequently used in EDs for procedural sedation as well as an induction agent for intubation, but has only recently been proposed as a treatment for agitation. Dissociative anesthesia occurs in 1-2 min intravenously and approximately 3 min in intramuscular administration (14, 15) .
In particular, ketamine has been proposed as an alternative to traditional antipsychotic treatment in the treatment of severe acute agitation (13, 16, 17) . The American College of Emergency Physicians' White Paper on Excited Delirium Syndrome describes the benefits of ketamine as a fast-acting medication in agitated and violent patients with a low rate of side effects (18) . The rapid onset of ketamine, under 5 min, compares favorably to haloperidol and droperidol, in which peak sedation can take more than 20 min (19, 20) . Most of the literature focuses on the traditional uses of ketamine for procedural sedation primarily involving children or induction for intubation. Little published research has been done on its use for the treatment of acute agitation in EDs, though one prehospital case series has shown significant decreases in oxygen saturation after administration (21) .
The oxygen desaturations in this case series are puzzling, particularly because ketamine is thought by most emergency physicians to have few effects on vital signs. However, ketamine has been noted to worsen tachycardia and hypertension in nonagitated patients, and may be a mild respiratory depressant at high doses, with respiratory drive depressed approximately 15-22% (15, 22, 23) . Post administration, dysphoric emergence phenomena have been reported to occur in 10-20% of adult patients sedated with ketamine, though these are often mild and can be treated with low doses of midazolam (21) . Adjunctive use of benzodiazepines may be dispreferred in children, however, studies have shown no difference between midazolam and placebo groups in rates of recovery agitation and that benzodiazepines may increase the risk of adverse airway events in children (22, 24) .
Objectives
The purpose of this study is to examine the efficacy and safety of ketamine in the treatment of acute agitation in an ED setting. Given a recent report that ketamine use in the prehospital setting was associated with a surprising number of oxygen desaturations, the primary measurement of interest was any increases or decreases in vital signs after ketamine, particularly oxygen saturation (21) .
MATERIALS AND METHODS

Study Design and Setting
This is an historical cohort study at two university EDs, one urban academic teaching hospital, and one suburban community hospital. Combined, these EDs treat approximately 65,000 patients per year. This study was approved by the local institutional review board prior to data collection.
Selection of Participants
The cohort was identified by a keyword search of the electronic medical record (EMR) for all patients who received ketamine between September 15, 2004 and June 6, 2012. Patients were included if ketamine was administered as treatment for acute agitation. Agitation was defined, following recent American Association for Emergency Psychiatry BETA project guidelines, as ''an extreme form of arousal that is associated with increased verbal and motor activity'' (25) . This definition was operationally adapted for use by including situations where the patient was noted to be physically aggressive with staff, require restraints, or have increased verbal/motor activity interfering with treatment. Patients were excluded if they received ketamine for any other reason, including procedural sedation or intubation, or if the chart was irretrievable.
The following variables were queried from the EMR: age, sex, and chief complaint. The following data were then abstracted by blinded research associates: patient vital signs (heart rate, blood pressure, respiratory rate, and oxygen saturation), route/dose/time of ketamine administration, previous administration of antipsychotics or benzodiazepines, additional calming medication within 3 h, alcohol levels measured via serum alcohol/breathalyzer, and urine toxicology lab results when available. If available, preadministration vital signs were recorded as close to the initial administration of ketamine as possible. If available, postadministration vitals were recorded for both the lowest and highest values of a particular vital sign parameter that were recorded within 4 h of administration. Additional calming medication was defined as additional antipsychotics, benzodiazepines, or ketamine administered for agitation within 3 h of the initial dose of ketamine. Although 3 h is not based on the half-life of ketamine, this figure has been used in other agitation investigations of this type (26) (27) (28) (29) . All records were evaluated by a minimum of three researchers who were trained on use of the EMR. At least 2 research assistants evaluated the EMR for each patient visit and selected those cases where ketamine was given for agitation; once all researchers had completed their review, the results were compared. Full consensus between the researchers was required for inclusion. Patients selected for inclusion subsequently had their EMR further evaluated for return to the ED for exacerbation of any psychiatric issues after administration of ketamine.
Data Collection and Processing
All data were entered into a standardized computer worksheet using Excel 2010 (Microsoft, Redmond, WA), and then checked for nonsensical values. Change in vital signs within 4 h after administration of ketamine was calculated relative to the baseline vital sign preadministration within each patient to prevent small changes in baseline vital signs from skewing the analysis across patients. Four hours postmedication administration was chosen, as this has been used in other investigations of this type and is approximately equal to two half-lives of ketamine (t1/2 = 2.17 h) (23, (26) (27) (28) (29) . Hypoxia after administration of ketamine was defined as an oxygen saturation of <90%.
Outcome Measures
The primary outcome measures were change in vital signs postadministration and the need for any additional calming medication. Vital sign changes were calculated within a particular patient, as noted above.
Primary Data Analysis
Descriptive statistics were used to evaluate patient characteristics such as age, gender, change in vitals, ketamine dose, and proportions of patients who received additional calming medication within 3 h.
RESULTS
Over the study period, 459 patients who received ketamine in the ED were identified. Thirty-two cases involving 27 patients met study inclusion and exclusion criteria and were subjected to further analysis. The remaining 427 patient visits received ketamine for nonagitation-related causes, primarily for procedural sedation or induction of intubation. One autistic, nonverbal patient who was uncooperative with treatment received ketamine on five separate visits. The age range of the study group was from 9 to 77 years (average age of 35 6 16 years; 20 males). Weight was recorded in five patient visits. Discharge diagnoses, age, and gender for each patient are listed in Table 1 . A total of 17 patient visits received intramuscular (i.m.) ketamine, and 15 received intravenous (i.v.) administration. In 18 (56.2%) cases, a patient received medication for agitation prior to being administered ketamine, most often a combination of an antipsychotic and a benzodiazepine. On 20 patient visits (62.5%), additional calming medication was utilized, most often additional ketamine. In eight (25%) visits, both pre-and postadministration medication was required. Thirteen patients intoxicated with alcohol or other substances (40.6%) required additional calming medication at a higher rate than those who were not (84.6% vs. 47.4%). A summary of medication and intoxication can be found in Table 2 . In no cases were dysphoric emergence reactions noted, and in no cases did patients return to the ED for noted exacerbations of psychiatric conditions due to ketamine.
There were sufficient data to evaluate postadministration change in systolic blood pressure (SBP) in 22 visits with an average preadministration SBP of 131 6 20 mm Hg. Within 4 h of administration, the highest recorded SBP for each patient showed an average increase of 17 6 25 mm Hg from the patient's baseline. The lowest recorded SBP in the same time period showed an average drop of 14 6 24 mm Hg. Change in heart rate was evaluated in 25 cases; the average preadministration heart rate was 98 6 23 beats/min. The average highest increase from baseline was 8 6 17 beats/min, and the largest decrease was 10 6 18 beats/min. Twenty-two cases provided oxygen saturation data in which the preadministration average was 98 6 2%. Postadministration average highest increase was 1.1 6 1.7%, and average largest decrease was 0.6 6 2.2%. No patients became hypoxic; the lowest oxygen saturation after administration was 94%. A summary of change in SBP and heart rate can be found in Table 3 . 
DISCUSSION
Several case reports have documented the potential usefulness of ketamine in severe agitation (13, 21, 30, 31) . The putative advantages of this medication for agitation include rapid onset, the preservation of airway reflexes, and the ability to administer either i.m. or i.v., which may itself be particularly useful if i.v. access is not easily obtained. In addition, sedation is often achieved reliably with one dose (23) . Compared to other agents, the halflife of ketamine is relatively short, potentially allowing more rapid disposition of agitated patients (23). Potential disadvantages of ketamine include the fact that patients who are in a dissociative state are unable to participate in their own care (4, 5, 10) . Ketamine also does not treat the underlying cause of agitation, and if the etiology of the agitation persists, patients may require multiple doses of additional calming medications. In this study, for instance, patients with substance/alcohol intoxication needed calming medication at higher rates. Finally, there is evidence from at least one double-blind placebocontrolled trial that subanesthetic doses of ketamine may worsen psychosis, which may make use of this medication inappropriate in patients who have a psychiatric cause of their illness (32) .
Little has been published on the use of ketamine for agitation. Roberts & Geeting described in a case study the successful treatment of an acutely agitated and violent patient with i.m. ketamine without major adverse effects, and a case series by Le Cong et al. reported that ketamine provided adequate sedation in agitated psychiatric patients who had not responded to treatment with benzodiazepines, without any major adverse effects (13, 30) . However, these report did not follow long term to confirm any worsening of psychosis after administration.
Much of the ED literature has focused on changes in vital signs. Burnett et al. report on several patients administered ketamine in the prehospital setting who had surprising decreases in oxygen saturations (21) . In terms of other vital sign parameters, increases in blood pressure and heart rate are frequently seen, but are rarely clinically significant (15) . This is true in the study above as well, in which increases in blood pressure and heart rate are frequently present but not noted as significant. In four cases, the highest recorded blood pressure after ketamine administration was lower than the predose SBP; this trend was also seen in heart rate in eight cases. In these cases, the effect of calming during an agitated episode on vitals may outweigh any changes induced by ketamine. Additionally, in no cases were significant changes in oxygen saturation noted, and no patients became hypoxic, contrary to the results seen in prehospital literature.
Slightly over half of the cases (62.5%) required additional medication for agitation after receiving ketamine, suggesting ketamine alone in the dose used is often not enough to resolve agitation. This is not unexpected as typically, ketamine was being used to gain rapid and safe control of severely agitated patients to facilitate a more structured medical evaluation. As ketamine has not been proposed specifically as a treatment for agitation from undertreated psychiatric illnesses or even sympathomimetic drug intoxication, but rather as a means to permit initial work-up of an agitated patient, it is perhaps not surprising to find that the majority of patients required additional medications.
Of interest, there were eight cases (Table 2: patients  14, 15, 16, 18, 19, 20, 24, and 25) where multiple doses of an antipsychotic or a benzodiazepine were given without resolution of agitation. Once given ketamine, these patients either did not require additional calming medication at all or did not need it within 3 h. Two of these patients, 18 and 19, received a ''B-52'' consisting of haloperidol, lorazepam, and diphenhydramine, traditionally thought to be extremely effective in sedating agitated patients, yet still required ketamine to resolve agitation. This may highlight ketamine's usefulness with severely agitated patients, as well as introducing ketamine as a potential alternate medication for patients nonresponsive to traditional pharmacological interventions.
Limitations
The retrospective, case series nature of this study may suffer from selection bias, as patients were not prospectively randomized and enrolled in treatment arms. The small patient population of the study also limits the ability to generalize to other populations. Incomplete charting led to a lack of vitals for several of the patients, decreasing our ability to further evaluate ketamine's reported effects on vital signs. A patient's weight is not routinely included in ED charts, and so precludes further evaluation of the appropriateness of dosing in most cases.
CONCLUSIONS
Relative to other pharmacologic treatments for agitation, ketamine is infrequently used in the ED. We found that ketamine was used without any major adverse effects on vital signs, even in a population with 21.9% alcohol intoxication. However, a high proportion (62.5%) of patients required additional pharmacologic treatment for their agitation, implying that ketamine itself is not an ideal treatment for the underlying cause of agitation, but rather a means of initial management of severe agitation. A prospective study is warranted to further clarify the safety and efficacy of the use of ketamine in this situation.
